Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microglia and multiple sclerosis.

Carolyn Jack1, Francesca Ruffini, Amit Bar-Or

  • 1Neuroimmunology Unit, Montreal Neurological Institute, Montreal, Quebec, Canada.

Journal of Neuroscience Research
|June 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abnormal B-Cell Exosome Proapoptotic and Antiapoptotic Cargo in Multiple Sclerosis: Potential Implication in Progressive Disease Biology.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Bruton's tyrosine kinase inhibitors: a new class of multiple sclerosis therapeutics.

The Lancet. Neurology·2026
Same author

Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND Study.

European journal of neurology·2026
Same author

Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.

Lancet (London, England)·2026
Same author

Prevalence and Characteristics of North American Indigenous Inflammatory Skin Disease: A Systematic Scoping Review.

International journal of dermatology·2026
Same author

The Effect of Ocrelizumab on Anti-JC Virus Antibody Index.

Brain and behavior·2026
Same journal

miR-19a-3p and miR-19b-3p Promote Microglia Activation Associated With Neuroinflammation.

Journal of neuroscience research·2026
Same journal

Correction to "Chronic Nicotine and Smoke Treatment Modulate Dopaminergic Activities in Ventral Tegmental Area and Nucleus Accumbens and the γ-Aminobutyric Acid Type B Receptor Expression of the Rat Prefrontal Cortex".

Journal of neuroscience research·2026
Same journal

EXPRESSION OF CONCERN: Hypoxia-Induced Deactivation of NGF-Mediated ERK1/2 Signaling in Hippocampal Cells: Neuroprotection by Acetyl-L-Carnitine.

Journal of neuroscience research·2026
Same journal

DKK1 Targeting in Corneal Schwann Cells Rescues Axonal Regeneration and Mechanosensory Function After Corneal Injury.

Journal of neuroscience research·2026
Same journal

An Examination of Task-Evoked fMRI Data Processing in Functional Connectivity.

Journal of neuroscience research·2026
Same journal

Association of Interhemispheric Structural Integrity With Transcallosal Interhemispheric Inhibition in People With Chronic Stroke.

Journal of neuroscience research·2026
See all related articles

Microglia, key immune cells in the central nervous system (CNS), drive multiple sclerosis (MS) inflammation and injury. Modulating microglial responses is crucial for limiting CNS damage and promoting recovery in MS patients.

Area of Science:

  • Neuroimmunology
  • Innate Immunity

Background:

  • Microglia are central to all stages of multiple sclerosis (MS).
  • They act as innate immune cells, responding to danger signals in the central nervous system (CNS).
  • Toll-like receptor (TLR) engagement by ligands triggers microglial inflammatory responses.

Purpose of the Study:

  • To explore the role of microglia in MS pathogenesis.
  • To understand how microglial interactions influence adaptive immunity.
  • To identify therapeutic strategies targeting microglial function in MS.

Main Methods:

  • Analysis of microglial activation and function in the CNS.
  • Investigation of Toll-like receptor (TLR) signaling pathways.
  • Assessment of microglial-mediated antigen presentation and immune cell interactions.

Related Experiment Videos

Main Results:

  • Microglial TLR engagement modulates antigen presentation, impacting adaptive immunity.
  • Bidirectional feedback occurs between CNS-resident and infiltrating immune cells.
  • Microglial phagocytosis and effector molecules, like reactive nitrogen species, contribute to CNS injury, particularly oligodendrocyte damage.

Conclusions:

  • Microglia play a critical role in MS initiation, propagation, and tissue damage.
  • Therapeutic strategies must modulate microglial dynamics to limit CNS injury.
  • Protecting the CNS and promoting recovery requires targeted modulation of innate immune responses.